Apr 3, 2019

Oncolytics Biotech(R) to Present at the 18th Annual Needham Healthcare Conference

Apr 2, 2019

Oncolytics Biotech (R) Presents Positive Clinical Biomarker Data at the American Association for Cancer Research Annual Meeting 2019

Mar 28, 2019

Oncolytics Biotech (R) Announces a Publication Highlighting Synergistic Effect of Pelareorep with a Proteasome Inhibitor in Preclinical Models of Multiple Myeloma

Mar 8, 2019

Oncolytics Biotech (R) Announces 2018 Year-End Results and Operational Highlights

Mar 1, 2019

Oncolytics Biotech(R) to Host Conference Call to Discuss Year End Financial Results and Operational Highlights

Feb 27, 2019

Oncolytics Biotech(R) Presents Biomarker Data in Second-line Pancreatic Cancer at AACR

Feb 11, 2019

Oncolytics Biotech(R) Announces Spanish Regulatory Approval of AWARE-1 Window of Opportunity Study in Breast Cancer

Feb 4, 2019

Oncolytics Biotech(R) to Present at the 21st Annual BIO CEO & Investor Conference

Dec 12, 2018

Oncolytics Biotech® Announces First Patient Treated in Study Combining Pelareorep, Carfilzomib and the Checkpoint Inhibitor Opdivo® in Multiple Myeloma

Dec 3, 2018

Oncolytics Biotech® Announces Increased PD-L1 Expression When Combining Pelareorep with a Proteasome Inhibitor in Poster Presentation at the 60th American Society of Hematology Annual Meeting & Exposition